SJS Investment Consulting’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
Other funds holding ABBV
ATO
SJS Investment Consulting's ABBV Position: Q2 2026 in Review
SJS Investment Consulting increased its AbbVie (ABBV) stake by 8.5% in Q2 2026, buying an estimated $32.9K and bringing the position to 1,943 shares worth $489K. The position accounts for 0.05% of the portfolio, ranked #94.
SJS Investment Consulting first reported a position in ABBV in Q4 2021 and has held it in 18 quarters since. The position peaked at $523K in Q1 2025. 1,743 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.
- SJS Investment Consulting held 1,943 shares of AbbVie worth $489K as of Q2 2026.
- SJS Investment Consulting bought 153 AbbVie shares in Q2 2026, an estimated $32.9K.
- AbbVie made up 0.05% of SJS Investment Consulting's portfolio in Q2 2026, its #94 holding.
- SJS Investment Consulting first reported a position in AbbVie in Q4 2021 and has held it in 18 quarters since.
- SJS Investment Consulting's AbbVie position peaked at $523K in Q1 2025.
- 1,743 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.
Based on SJS Investment Consulting's 13F filing for Q2 2026, filed 22 Jul 2026.